Press Releases Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Real-time Estimate Cboe BZX Other stock markets 12:48:55 09/05/2024 am IST			5-day change	1st Jan Change
4.78 ^USD	+8.64%		+8.02%	-62.53%

16/04	Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/04	North American Morning Briefing : Stock Futures -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Windtree Therapeutics Regains Compliance with Nasdaq	07/05	AQ
Windtree Therapeutics : April'24 Corporate Presentation	24/04	PU
Windtree Therapeutics Announces Reverse Stock Split	18/04	AQ
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates	17/04	AQ
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing	09/04	AQ
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research	01/02	AQ
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives	31/01	AQ
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company	25/01	AQ
WINDTREE THERAPEUTICS ANNOUNCES LICENSE AGREEMENT WITH LEE'S PHARMACEUTICALS TO DEVELOP AND COMMERCIALIZE ISTAROXIME, DUAL MECHANISM SERCA2A ACTIVATORS AND ROSTAFUROXIN FOR GREATER CHINA, ASIA PACIFIC REGION	18/01	AQ
Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region	17/01	AQ
WINDTREE THERAPEUTICS ANNOUNCES REDUCTION IN ARRYTHMIAS IN A NEW STUDY WITH ISTAROXIME AND A PURE SERCA2A ACTIVATOR	03/01	AQ
Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator	03/01	AQ
Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock	18/12	AQ
Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator Patent	16/11	AQ
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates	10/11	AQ
Windtree to Present at the Sidoti Micro Cap Conference on November 16th	08/11	AQ
Windtree to Present at the ThinkEquity Conference on October 19th in New York City	12/23/12	AQ
Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th	10/23/10	AQ
Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th	03/23/03	AQ
Windtree Therapeutics : September'23 Corporate Presentation	14/23/14	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Press Releases

Filters